FDA removes hold on pivotal gene therapy trial

Abeona Therapeutics announced that the U.S. FDA has removed its clinical hold on the company ’s pivotal Phase 3 clinical trial evaluating gene therapy for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news